tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ABCL is currently covered by 7 analysts with an average price target of $9.75. This is a potential upside of -$2.05 (-17.37%) from yesterday's end of day stock price of $11.8.
Abcellera Biologics's activity chart (see below) currently has 76 price targets and 76 ratings on display. The stock rating distribution of ABCL is 84.62% BUY and 15.38% HOLD.
Analysts average stock forecasts to be materialized ratio is 47.88% with an average time for these price targets to be met of 160 days.
Highest price target for ABCL is $13, Lowest price target is $4, average price target is $9.75.
Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 24-Sep-2026.
Currently out of the existing stock ratings of ABCL, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Sep-2026
$13
$1.2 (10.17%)
$24
24 days ago
(24-Sep-2026)
1/3 (33.33%)
$0.35 (2.77%)
4
Buy Since 05-Jan-2021
$9
$-2.8 (-23.73%)
$8
2 months 12 days ago
(06-Aug-2026)
5/9 (55.56%)
$2.47 (37.83%)
312
Buy Since 05-May-2026
$12
$0.2 (1.69%)
$11
2 months 12 days ago
(06-Aug-2026)
3/3 (100%)
$5.47 (83.77%)
53
Hold Since 05-Nov-2024
$11
$-0.8 (-6.78%)
3 months 11 days ago
(07-Jul-2026)
2/4 (50%)
$3.31 (43.04%)
561
Buy Since 16-May-2025
$12
$0.2 (1.69%)
$10
4 months 26 days ago
(22-May-2026)
5/5 (100%)
$6.8 (130.77%)
275
What is ABCL (Abcellera Biologics) average time for price targets to be met?
Which analyst most recently updated their price target on ABCL (Abcellera Biologics)?
Which analyst has the most public recommendations on ABCL (Abcellera Biologics)?
Which analyst is the currently most bullish on ABCL (Abcellera Biologics)?
Which analyst is the currently most reserved on ABCL (Abcellera Biologics)?
